Native kidney small renal masses in patients with kidney transplants: Does chronic immunosuppression affect tumor biology?

Ari P. Bernstein, Meenakshi Davuluri, Matthew DeMasi, Alexander I. Sankin, Kara Watts, Ahmed Aboumohamed, Joshua M. Stern, Juan Rocca, Stuart Greenstein, Jay A. Graham, Maria Ajaimy, Luz E. Liriano-Ward, Judy Sarungbam, Evan Z. Kovac

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: We compared clinicopathologic characteristics and outcomes of radical nephrectomy (RN) for small renal masses (SRM) in patients with end-stage renal disease (ESRD) before or after transplant at a high-volume urologic and transplant center. Methods: We performed a retrospective review of patients with ESRD (glomerular filtration rate [GFR] <15 mL/min) who underwent RN for suspected malignant SRM from 2000–2018. Group 1 consisted of patients who underwent RN after transplant; group 2 underwent RN prior to transplant, and group 3 underwent RN without subsequent transplant. Dominant tumor size and histopathologic characteristics, recurrence, and survival outcomes were compared between groups. Chi-squared and Mann-Whitney U tests were used to compare categorical and continuous baseline and histopathologic characteristics, respectively. Univariate analysis and log rank test were used to compare RCC recurrence rates. Results: We identified 34 nephrectomies in group 1, 27 nephrectomies in group 2, and 70 nephrectomies in group 3. Median time from transplant to SRM radiologic diagnosis in group 1 was 87 months, and three months from diagnosis to nephrectomy for all groups. There were no statistically significant differences between pathologic dominant mass size, histologic subtype breakdown, grade, or stage between the groups. Rates of benign histology were similar between the groups. Univariate analysis did not reveal a statistically significant difference in recurrence-free survival between the groups (p=0.9). Conclusions: Patients undergoing nephrectomy before or after transplant for SRM have similar indolent clinicopathologic characteristics and low recurrence rates. Our results suggest that chronic immunosuppression does not adversely affect SRM biology.

Original languageEnglish (US)
JournalCanadian Urological Association Journal
Volume15
Issue number10
DOIs
StatePublished - Oct 2021

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Native kidney small renal masses in patients with kidney transplants: Does chronic immunosuppression affect tumor biology?'. Together they form a unique fingerprint.

Cite this